NAFLD defined as elevated ALT > 40 U/L for men or > 30 U/L for women during at least two time points at least 6 months apart within a 2-year window period at any point prior to enrolment after the exclusion of other causes of liver disease. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.